Literature DB >> 24138456

Development of activity-based probes for ubiquitin and ubiquitin-like protein signaling pathways.

Heeseon An1, Alexander V Statsyuk.   

Abstract

Ubiquitin and ubiquitin-like (UBL) proteins regulate a vast variety of cellular functions. Some UBL proteins are present in all cell types, while others are expressed only in certain cells or under certain environmental conditions. This highlights the central role of UBL systems in regulation of ubiquitous as well as specific cellular functions. UBL proteins share little amino acid sequence identity to each other, yet they share similar 3D shapes, which is exemplified by the β-grasp fold. Central to UBL protein signaling pathways are UBL protein-activating E1 enzymes that activate the C-terminus of UBL proteins for subsequent conjugation to the protein substrates. Due to their critical roles in biology, E1 enzymes have been recognized as emerging drug targets to treat human diseases. In spite of their biological significance, however, methods to discover UBL proteins and to monitor the intracellular activity of E1 enzymes are lacking. Thus, there is a critical need for methods to evaluate the intracellular mechanisms of action of E1 enzyme inhibitors. Here we describe the development of a mechanism-based small-molecule probe, ABP1, that can be used to discover and to detect active UBL proteins, and to monitor the intracellular activity of E1 enzymes inside intact cells. The developed probe can also be used to profile the selectivity of E1 enzyme-targeting drugs in vitro and inside intact cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138456     DOI: 10.1021/ja4099643

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  17 in total

1.  Covalent Tethering of Fragments For Covalent Probe Discovery.

Authors:  Stefan G Kathman; Alexander V Statsyuk
Journal:  Medchemcomm       Date:  2016-01-28       Impact factor: 3.597

2.  UbFluor: A Fluorescent Thioester to Monitor HECT E3 Ligase Catalysis.

Authors:  David T Krist; Peter K Foote; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2017-03-02

3.  Catalytically Important Residues of E6AP Ubiquitin Ligase Identified Using Acid-Cleavable Photo-Cross-Linkers.

Authors:  David T Krist; Alexander V Statsyuk
Journal:  Biochemistry       Date:  2015-07-20       Impact factor: 3.162

Review 4.  Bacteria-host relationship: ubiquitin ligases as weapons of invasion.

Authors:  Timurs Maculins; Evgenij Fiskin; Sagar Bhogaraju; Ivan Dikic
Journal:  Cell Res       Date:  2016-03-11       Impact factor: 25.617

5.  An inhibitor of ubiquitin conjugation and aggresome formation.

Authors:  Heeseon An; Alexander V Statsyuk
Journal:  Chem Sci       Date:  2015-06-22       Impact factor: 9.825

6.  Dynamic recruitment of ubiquitin to mutant huntingtin inclusion bodies.

Authors:  Katrin Juenemann; Anne H P Jansen; Luigi van Riel; Remco Merkx; Monique P C Mulder; Heeseon An; Alexander Statsyuk; Janine Kirstein; Huib Ovaa; Eric A Reits
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

Review 7.  Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors:  Michaelyn C Lux; Lisa C Standke; Derek S Tan
Journal:  J Antibiot (Tokyo)       Date:  2019-04-15       Impact factor: 2.649

Review 8.  Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insights.

Authors:  David S Hewings; John A Flygare; Matthew Bogyo; Ingrid E Wertz
Journal:  FEBS J       Date:  2017-03-10       Impact factor: 5.542

Review 9.  Anticancer drug discovery by targeting cullin neddylation.

Authors:  Qing Yu; Yihan Jiang; Yi Sun
Journal:  Acta Pharm Sin B       Date:  2019-09-20       Impact factor: 11.413

10.  A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes.

Authors:  Monique P C Mulder; Katharina Witting; Ilana Berlin; Jonathan N Pruneda; Kuen-Phon Wu; Jer-Gung Chang; Remco Merkx; Johanna Bialas; Marcus Groettrup; Alfred C O Vertegaal; Brenda A Schulman; David Komander; Jacques Neefjes; Farid El Oualid; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2016-05-16       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.